| http://www.w3.org/ns/prov#value | - In the early 1990s, as the nation searched for drugs to combat diseases such as HIV/AIDS, the FDA was willing to take some more risks, and there was a spike of drug approvals as it looked more towards effectiveness rather than risk aversion.
|
